Indian Pharma giant Ranbaxy has announced that English Crown Court has quashed the U.K. Serious Fraud Office's (SFO) bid to prosecute Ranbaxy UK limited on the charges of fraud and price fixing.
The Crown court declined to send the case to the Court of Appeal and said the Serious Fraud Office should approach the court directly for permission.
Earlier in April 2006, SFO initiated criminal proceedings against RanbaxyUK limited on charges of fixing prices of medicines between April 1, 1998, and September 30, 2000.
No comments:
Post a Comment